Cited by 2,758Genomics and Rare DiseasesGenetic Associations and EpidemiologyGenomics and Phylogenetic Studies

ClinVar: public archive of interpretations of clinically relevant variants

Open access
Landrum, Melissa J., Lee, Jennifer M., Benson, Mark, Brown, Garth, Chao, Chen, Chitipiralla, Shanmuga, Gu, Baoshan, Hart, Jennifer +11 more·2016·Nucleic Acids Research

Abstract

ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) at the National Center for Biotechnology Information (NCBI) is a freely available archive for interpretations of clinical significance of variants for reported conditions. The database includes germline and somatic variants of any size, type or genomic location. Interpretations are submitted by clinical testing laboratories, research laboratories, locus-specific databases, OMIM®, GeneReviews™, UniProt, expert panels and practice guidelines. In NCBI's Variation submission portal, submitters upload batch submissions or use the Submission Wizard for single submissions. Each submitted interpretation is assigned an accession number prefixed with SCV. ClinVar staff review validation reports with data types such as HGVS (Human Genome Variation Society) expressions; however, clinical significance is reported directly from submitters. Interpretations are aggregated by variant-condition combination and assigned an accession number prefixed with RCV. Clinical significance is calculated for the aggregate record, indicating consensus or conflict in the submitted interpretations. ClinVar uses data standards, such as HGVS nomenclature for variants and MedGen identifiers for conditions. The data are available on the web as variant-specific views; the entire data set can be downloaded via ftp. Programmatic access for ClinVar records is available through NCBI's E-utilities. Future development includes providing a variant-centric XML archive and a web page for details of SCV submissions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkv1222

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The individual gene estimates are concordant with the absence of any de novo mutations in NIPA1, NIPA2, CYFIP1, and TUBGCP5 in ClinVar.

    “Our individual gene estimates are, however, concordant with the absence of any de novo mutations in NIPA1, NIPA2, CYFIP1 and TUBGCP5 in the public archive of interpretations of clinically relevant variants, ClinVar accessed March 2018 (http://www.ncbi.nlm.nih.gov/clinvar).47”

    From Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice (2019) · cites this paper as [47]

    The Introduction identifies ClinVar as a public database of submitted variant interpretations, supporting the citation’s identification of the archive. The paper does not report whether de novo mutations in NIPA1, NIPA2, CYFIP1, or TUBGCP5 were absent from ClinVar in March 2018; searches for those genes and de novo mutations found no such passage. The citing authors’ individual gene estimates are their own finding, not a finding attributed to this source. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Some variants designated with the 'increased risk' classification in DTC raw data or by a third-party interpretation service were classified as benign at Ambry Genetics as well as several other clinical laboratories.

    “In addition, some variants designated with the “increased risk” classification in DTC raw data or by a third-party interpretation service were classified as benign at Ambry Genetics as well as several other clinical laboratories, and are noted to be common variants in publicly available population frequency databases.”

    From False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care (2018) · cites this paper as [21]

    The Introduction and Maintenance sections describe ClinVar’s aggregation of laboratory interpretations and how it displays conflicts, but neither reports the claimed DTC classifications or benign assessments by Ambry Genetics and other laboratories. Searches for “Ambry,” “increased risk,” and “direct-to-consumer” found no passage addressing those variants. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., Jang, W., Katz, K., Ovetsky, M., Riley, G., Sethi, A., Tully, R., Villamarin-Salomon, R., Rubinstein, W., & Maglott, D. R.
Affiliations
National Institutes of Health (US)
Corresponding author
Landrum, Melissa J.
Venue
Nucleic Acids Research
Published
2015-11-17
Volume
44
Issue
D1
Pages
D862-D868
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2174602966
Cited by
2,758
References
16
Citations by year
2026: 179 · 2025: 241 · 2024: 238 · 2023: 242 · 2022: 252 · 2021: 271 · 2020: 289 · 2019: 328 · 2018: 352 · 2017: 265 · 2016: 94 · 2014: 1
FWCI
163.59
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Nucleic Acids Research (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health
  • U.S. National Library of Medicine
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Keywords
ClinVar, variant interpretation, clinical significance, germline mutations, somatic mutations, variant nomenclature, HGVS, data standards
MeSH terms
Disease, Genes, Humans, Genetic Variation, Genome, Human, Databases, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review